II. Epidemiology
- Severe disease is rare- Prevalance: 1:100,000 to 1:300,000 live births
 
- Adult form (less severe)- Prevalence: 1:3100 to 1:508
 
III. Pathophysiology
- Rare genetic metabolic disorder- Gene defect encoding activity of tissue non-specific Alkaline Phosphatase (TNSALP)- More than 400 mutations identified
- Autosomal Recessive or Autosomal Dominant inheritance
 
- TNSALP substrates accumulate- Inorganic pyrophosphate
- Pyridoxal-5'-phosphate
 
 
- Gene defect encoding activity of tissue non-specific Alkaline Phosphatase (TNSALP)
- Serum and bone Alkaline Phosphatase deficiency- Hypercalcemia
- Ethanolamine phosphatemia and phosphaturia
 
- Associated with severe skeletal defects similar to Vitamin D-resistant Rickets- Failed calcification of calvarium
- Costochondral junction beading
- Rachitic bone changes
 
IV. Types
- Current classification- Severe (recessive inheritance)- Perinatal
- Infantile Severe
 
- Moderate (Autosomal Dominant or recessive inheritance)
- Mild
 
- Severe (recessive inheritance)
- Historical Classification- Perinatal
- Prenatal benign
- Infantile
- Childhood
- Adult
- Odontohypophosphatasia
 
V. Findings
- Lung
- Gastrointestinal
- Renal- Renal calcinosis
 
- Growth and Development- Fetal demise (in utero)
- Failure to Thrive
 
- Dental (Odontohypophosphatasia)- Premature deciduous teeth loss
- Early adult teeth loss
 
- Musculoskeletal- Osteomalacia
- Skeletal defects
- Recurrent, poorly healing Fractures
- Movement Disorders and Muscle Weakness
 
VI. Labs
- 
                          Serum Alkaline Phosphatase
                          - Low for age
 
- Tissue non-specific Alkaline Phosphatase (TNSALP) natural substrate increased levels- Pyridoxal 5'-phosphate
- Phosphoethanolamine
 
VIII. Management
- Multidisciplinary team management
- Dietary Calcium restriction in children
- Targeted enzyme replacement therapy
